Small molecules as modulators of regulated cell death against ischemia/reperfusion injury

Area of Science:

• Biomedical Science
• Molecular Biology
• Pathophysiology

Background:

• Ischemia/reperfusion (IR) injury is a significant global health concern with limited therapeutic options.
• The complex mechanisms of IR injury necessitate novel therapeutic targets.
• Regulated cell death (RCD) in endothelial and parenchymal cells presents a promising avenue for intervention.

Purpose of the Study:

• To explore the role of small molecules in modulating RCD pathways relevant to IR injury.
• To elucidate the mechanisms by which small molecules protect against IR injury.
• To evaluate the potential of combination therapies using small molecules.

Main Methods:

• Review of recent advances in IR injury research.
• Analysis of small molecule interactions with RCD pathways (apoptosis, necroptosis, autophagy, ferroptosis, pyroptosis, parthanatos).
• Examination of small molecules targeting endothelial and parenchymal cells.

Main Results:

• Small molecules demonstrate protective effects against various forms of RCD in the context of IR injury.
• These molecules function by targeting specific cell types to mitigate IR-induced damage.
• Combined small molecule therapies exhibit potent synergistic effects.

Conclusions:

• Small molecules targeting RCD pathways represent a novel therapeutic strategy for IR injury.
• Targeting multiple cell types with combined small molecules enhances therapeutic efficacy.
• This approach lays the groundwork for developing new treatments to attenuate IR injury.